Sandra Steiner
15Patents
3h-index
48Co-inventors
60Inventor score
Filing activity: Dec 7, 2001 → Feb 25, 2025
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7642068B2 | Multiple-valent opsonophagocytic assay selection panel arrays and uses therefor | Physics | 19 | Expired |
| US6815172B1 | Methods and compositions for opsonophagocytic assays | Emerging Cross-Sectional Technologies | 8 | Expired |
| US8178547B2 | Heterocyclic antiviral compounds | Chemistry; Metallurgy | 5 | Active |
| US7919104B2 | Functional epitopes of Streptococcus pneumoniae PsaA antigen and uses thereof | Emerging Cross-Sectional Technologies | 3 | Expired |
| US10730881B2 | Fused pyrimidine derivatives | Chemistry; Metallurgy | 2 | Active |
| US11708354B2 | 2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds | Chemistry; Metallurgy | 1 | Active |
| US12209091B2 | Isoindolinone derivatives as selective allosteric inhibitors of Egfr mutant cancers | Human Necessities | 1 | Active |
| US10882848B2 | 2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds | Chemistry; Metallurgy | 1 | Active |
| US11117890B2 | Substituted isoindole allosteric EGFR inhibitors | Chemistry; Metallurgy | 1 | Active |
| US9101582B2 | Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogen | Human Necessities | 1 | Active |
| US8431134B2 | Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogen | Human Necessities | 0 | Active |
| US10669276B2 | Fused pyrimidine derivatives | Chemistry; Metallurgy | 0 | Active |
| US11840528B2 | Isoxazolyl ether derivatives as GABAA α5 PAM | Chemistry; Metallurgy | 0 | Active |
| US12421209B2 | Compounds | Chemistry; Metallurgy | 0 | Active |
| US12344613B2 | EGFR inhibitor for the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.